Skip to main content
. 2023 Jun 22;109(3):740–750. doi: 10.3324/haematol.2022.282424

Figure 1.

Figure 1.

Distribution of identified genomic breakpoint sequences. Distribution of the genomic breakpoint sequences that were identified among (A) patients (N=36) and (B) all follow-up samples (N=183) with matched genomic DNA polymerase chain reaction-based measurable residual disease (MRD) data and flow cytometry-based MRD data.